Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients - Summary - MDSpire

Dual-energy CT liver fat fraction as prognostic imaging biomarker in critically ill patients

  • By

  • Jennifer Erley

  • Julia Breckow

  • Kevin Roedl

  • Ann-Kathrin Ozga

  • Alidan Duoerkongjiang

  • Geraldine de Heer

  • Niklas Schubert

  • Fabian Pallasch

  • Christoph Burdelski

  • Stefan Kluge

  • Jin Yamamura

  • Gerhard Adam

  • Isabel Molwitz

  • August 6, 2025

  • 0 min

Share

Objective:

To investigate changes in liver DECT fat fraction (FF) in critically ill patients, specifically focusing on its correlation with in-hospital mortality, ICU prognostic scores, and length of ICU stay.

Key Findings:
  • Liver DECT FF is a reliable measure of liver steatosis in critically ill patients, with significant implications for patient management.
  • Changes in liver fat content over time were observed, indicating potential for monitoring disease progression.
  • Liver DECT FF correlated with in-hospital mortality and ICU prognostic scores, suggesting its prognostic value.
Interpretation:

Liver DECT FF serves as a potential prognostic imaging biomarker in critically ill patients, providing critical insights into liver health and associated clinical outcomes.

Limitations:
  • Retrospective design may introduce bias, potentially affecting the reliability of the findings.
  • Limited generalizability due to specific patient cohort.
  • Potential inter-observer variability in DECT FF measurements.
Conclusion:

DECT liver fat fraction is a promising tool for assessing liver steatosis and predicting outcomes in critically ill patients.

Original Source(s)

Related Content